Objective: Assessment of sensory neglect to measure sensory deficits following permanent middle cerebral artery occlusion (stroke) in rats
Gather these items before starting the experiment. Check off items as you prepare.
3 items available from ConductScience
Estimated: $10,505.00
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Currently, the only approved treatment for ischaemic stroke is tissue plasminogen activator, a clot-buster. This treatment can have dangerous consequences if not given within the first 4 h after stroke. Our group and others have shown progesterone to be beneficial in preclinical studies of stroke, but a progesterone dose-response and time-window study is lacking. We tested male Sprague-Dawley rats (12 months old) with permanent middle cerebral artery occlusion or sham operations on multiple measures of sensory, motor and cognitive performance. For the dose-response study, animals received intraperitoneal injections of progesterone (8, 16 or 32 mg/kg) at 1 h post-occlusion, and subcutaneous injections at 6 h and then once every 24 h for 7 days. For the time-window study, the optimal dose of progesterone was given starting at 3, 6 or 24 h post-stroke. Behavioural recovery was evaluated at repeated intervals. Rats were killed at 22 days post-stroke and brains extracted for evaluation of infarct volume. Both 8 and 16 mg/kg doses of progesterone produced attenuation of infarct volume compared with the placebo, and improved functional outcomes up to 3 weeks after stroke on locomotor activity, grip strength, sensory neglect, gait impairment, motor coordination and spatial navigation tests. In the time-window study, the progesterone group exhibited substantial neuroprotection as late as 6 h after stroke onset. Compared with placebo, progesterone showed a significant reduction in infarct size with 3- and 6-h delays. Moderate doses (8 and 16 mg/kg) of progesterone reduced infarct size and improved functional deficits in our clinically relevant model of stroke. The 8 mg/kg dose was optimal in improving motor, sensory and memory function, and this effect was observed over a large therapeutic time window. Progesterone shows promise as a potential therapeutic agent and should be examined for safety and efficacy in a clinical trial for ischaemic stroke.
Male Sprague-Dawley rats (12 months old) underwent either permanent middle cerebral artery occlusion or sham operations
Note: This creates the stroke model for testing
“We tested male Sprague-Dawley rats (12 months old) with permanent middle cerebral artery occlusion or sham operations on multiple measures of sensory, motor and cognitive performance”
Animals received intraperitoneal injections of progesterone at 1 hour post-occlusion
Note: Three dose levels tested: 8, 16, or 32 mg/kg
“For the dose-response study, animals received intraperitoneal injections of progesterone (8, 16 or 32 mg/kg) at 1 h post-occlusion”
Animals received subcutaneous injections of progesterone at 6 hours post-occlusion
Note: Same dose levels as initial injection
“subcutaneous injections at 6 h and then once every 24 h for 7 days”
Animals received subcutaneous injections once every 24 hours for 7 days following the 6-hour injection
Note: Continuation of treatment regimen
“subcutaneous injections at 6 h and then once every 24 h for 7 days”
In the time-window study, the optimal dose of progesterone was given starting at 3, 6, or 24 hours post-stroke
Note: Optimal dose determined from dose-response study
“For the time-window study, the optimal dose of progesterone was given starting at 3, 6 or 24 h post-stroke”
Rats were tested on sensory neglect test to measure sensory deficits following stroke
Note: Part of comprehensive behavioral assessment battery
“Behavioural recovery was evaluated at repeated intervals. Rats were killed at 22 days post-stroke and brains extracted for evaluation of infarct volume”
Rats were tested on grip strength, gait impairment, motor coordination, and spatial navigation tests
Note: Comprehensive functional outcome measures
“improved functional outcomes up to 3 weeks after stroke on locomotor activity, grip strength, sensory neglect, gait impairment, motor coordination and spatial navigation tests”
Rats were killed at 22 days post-stroke and brains extracted for evaluation of infarct volume
Note: Terminal endpoint for anatomical assessment
“Rats were killed at 22 days post-stroke and brains extracted for evaluation of infarct volume”
Animals underwent permanent middle cerebral artery occlusion or sham operations
No institutional citation data available yet.
